Opzelura Ruxolitinib Topical Uses Side Effects Dosage
What Is Opzelura? Opzelura (ruxolitinib) is a prescription-only topical cream approved by the Food and Drug Administration (FDA) to treat mild to moderate atopic dermatitis and nonsegmental vitiligo. Atopic dermatitis is the most common form of eczema and affects approximately 30% of the U.S. population. Opzelura is in a class of medications known as Janus kinase (JAK) inhibitors. JAK enzymes cause and promote types of inflammation in the body. Opzelura works by interfering with these enzymes, preventing inflammation that would otherwise lead to redness and itching of the skin....